2026 Anne S. De Groot: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	55	3812	3514	1747	1598	304	10453

Anne S. De Groot publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Anne S. De Groot sits on this spectrum.

62 publications 807+

This scientist: 304 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Anne S. De Groot D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Anne S. De Groot sits on this spectrum.

40 D-Index 157+

This scientist: 55 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Anne S. De Groot is affiliated with the University of Georgia in the United States. Their research primarily focuses on medicine, with significant contributions in the fields of immunology and microbiology.

The scientist's work spans several subfields, including immunology, molecular biology, epidemiology, infectious diseases, and radiology, nuclear medicine, and imaging. Their research topics cover diverse areas such as vaccines and immunoinformatics approaches, monoclonal and polyclonal antibodies research, immunotherapy and immune responses, animal virus infections studies, biosimilars and bioanalytical methods, SARS-CoV-2 and COVID-19 research, and influenza virus research studies.

Anne S. De Groot has published in a variety of scientific venues. Frequent publication sources include:

Frontiers in Immunology
Human Vaccines & Immunotherapeutics
Vaccines
AASV Annual Meeting
Expert Review of Vaccines

Their recent notable papers feature the following:

"Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools," 2020, Frontiers in Immunology
"T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation-Updated Consensus and Review 2020," 2020, Frontiers in Immunology
"Immunogenicity risk assessment of synthetic peptide drugs and their impurities," 2023, Drug Discovery Today
"Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy," 2021, Expert Review of Vaccines
"Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation," 2021, npj Vaccines

The scientist has collaborated frequently with several researchers, including:

William Martin
Leonard Moise
Andrés H. Gutiérrez
Frances Terry
Guilhem Richard

Best Publications

Immunogenicity of protein therapeutics

Anne S. De Groot;David W. Scott

641
Citations
Activation of natural regulatory T cells by IgG Fc–derived peptide “Tregitopes”

Anne S. De Groot;Leonard Moise;Julie A. McMurry;Erik Wambre

458
Citations
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation.

Vibha Jawa;Leslie P. Cousens;Michael Awwad;Eric Wakshull

274
Citations
From genome to vaccine: in silico predictions, ex vivo verification.

Anne S. De Groot;Andrew Bosma;Natasha Chinai;Julie Frost

255
Citations
Immuno‐informatics: Mining genomes for vaccine components

Anne S De Groot;Hakima Sbai;Caitlin Saint Aubin;Julie McMurry

253
Citations
Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics.

Anne S. De Groot;William Martin

238
Citations
Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences.

G. E. Meister;C. G. P. Roberts;J. A. Berzofsky;A. S. De Groot

218
Citations
Immunomics: discovering new targets for vaccines and therapeutics

Anne S. De Groot

201
Citations
Emerging Vaccine Informatics

Yongqun He;Rino Rappuoli;Anne S. De Groot;Robert T. Chen

180
Citations
De-immunization of therapeutic proteins by T-cell epitope modification.

A S De Groot;P M Knopp;W Martin

176
Citations
Clinical validation of the "in silico" prediction of immunogenicity of a human recombinant therapeutic protein.

E. Koren;A.S. De Groot;V. Jawa;K.D. Beck

170
Citations
T cell epitope: friend or foe? Immunogenicity of biologics in context.

Constanze A. Weber;Preema J. Mehta;Matt Ardito;Lenny Moise

157
Citations
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools.

Anne S De Groot;Leonard Moise;Frances Terry;Andres H Gutierrez

153
Citations
Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix.

J. R. A. Schafer;B. M. Jesdale;J. A. George;N. M. Kouttab

151
Citations
Tregitope update: Mechanism of action parallels IVIg

Leslie P. Cousens;Ryan Tassone;Bruce D. Mazer;Vasanthi Ramachandiran

149
Citations
From genome to vaccine--new immunoinformatics tools for vaccine design.

Anne S. De Groot;Jay A. Berzofsky

140
Citations
Prediction of immunogenicity for therapeutic proteins: state of the art.

Anne S De Groot;Leonard Moise

139
Citations
In Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity

Leslie P. Cousens;Nader Najafian;Federico Mingozzi;Wassim Elyaman

138
Citations
An Interactive Web Site Providing Major Histocompatibility Ligand Predictions: Application to HIV Research

Anne S. De Groot;Bill M. Jesdale;Evan Szu;James R. Schafer

138
Citations
Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008–2009 conventional influenza vaccine

Anne S. De Groot;Matt Ardito;Elizabeth M. McClaine;Leonard Moise

131
Citations
Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates.

Anne S De Groot;Anne S De Groot;Julie McMurry;Lenny Moise

126
Citations

Frequent Co-Authors

William J. Martin National Institutes of Health

David W. Scott Uniformed Services University of the Health Sciences

Federico Mingozzi Children's Hospital of Philadelphia

Ted M. Ross University of Georgia

Søren Buus University of Copenhagen

Mark C. Poznansky Harvard University

Samia J. Khoury American University of Beirut

David B. Weiner The Wistar Institute

Nader Najafian Brigham and Women's Hospital

Kenneth H. Mayer Harvard Medical School

External Links

Wikipedia of Anne S. De Groot Personal website of Anne S. De Groot

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open valuable career opportunities. Many students transition into nursing roles, which complement immunology expertise by focusing on patient care and treatment of immune-related conditions. Programs tailored for those without a nursing background, such as online absn programs for non nurses, provide an accelerated route to becoming a registered nurse.

If you're looking for accessible options, lpn programs easy to get into offer a practical entry point into nursing with shorter study durations, allowing you to gain hands-on experience in the healthcare field quickly. Building on this foundation, many pursue advanced degrees through what is the easiest np program to elevate their scope of practice, combining clinical expertise with specialized knowledge in immunology-related care.

For a streamlined nursing education, consider accelerated bsn programs for non nurses, which enable faster degree completion for career changers. These pathways not only expand your understanding of immunology in clinical settings but also enhance employment prospects across research, healthcare, and public health sectors.